Navigation Links
Organovo Reports Q3 2012 Financial Results, Provides Business Update
Date:11/16/2012

SAN DIEGO, Nov. 16, 2012 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo") a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its financial results for the three and nine month period ended September 30, 2012.

Third Quarter Corporate Highlights

  • National Institutes of Health three dimensional liver research grant revenue
  • Receipt of two issued patents, including Company's first assigned patent
  • Move to new, larger research and headquarters facility
  • Appointment of additional independent director to serve as Audit Committee Chairman
  • Third quarter 2012 revenues increased by $237,300 or approximately 102% over the same period in 2011, commensurate with the Company's continued delivery against collaborative research agreements and the initiation of research activities within the scope of a grant from the National Institutes of Health ("NIH").  Collaborative research agreement revenues contributed $141,800 or 60% of the revenue increase while grant revenues contributed $95,500.

    Cash receipts related to the reported revenues partially offset the Company's operating expenses and strengthened our balance sheet.  During the quarter the balance sheet was additionally strengthened through the receipt of approximately $1.7 million in capital from warrant and stock option exercises.  The Company had approximately $7.7 million cash on hand at the end of the quarter.  While the Company reported net earnings of approximately $38.5 million for the quarter, investors should note those earnings were primarily the result of a non-cash adjustment resulting from the change in fair value of our warrant liabilities.  The warrant liability is volatile in nature and is driven primarily by changes in the price of our Common stock, absent material changes in the number of warrants outstanding.  Investors should anticipat
    '/>"/>

    SOURCE Organovo Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
    2. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
    3. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
    4. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
    5. Organovo Announces Relocation and Commencement of Operations at Larger Facility
    6. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
    7. Organovo To Present At Lazard Healthcare Conference
    8. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    10. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/17/2014)... 17, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today the formation of a Medical Advisory Board ... Company as it advances the Phase 3 clinical ... of cutaneous T-cell lymphoma (CTCL), a rare class ...
    (Date:11/16/2014)... James Hill and Ken Crooks will co-present ... Later” scheduled for Thursday, November 20, 1-2 EST. ... many in the lab design domain by installing 27 ... chemistry teaching laboratories at Gallahue Hall. The renovation project ... growth within the chemistry program. Now, three years later, ...
    (Date:11/15/2014)... New York, NY (PRWEB) November 14, 2014 ... expansion plan, QuickSTAT is making significant investments in ... evolving world of modern cold chain and the ... will support QuickSTAT’s ongoing focus on customized logistics ... Towers and enhancement of existing facilities. There will ...
    (Date:11/15/2014)... (PRWEB) November 14, 2014 ... ‘ISCTR’ announced today that the society’s Governing Board ... Rowe, Edwards Lifesciences chief scientific officer and Dr. ... medical officer, Abbott Vascular. Mr. Rowe and ... medical device development experts. , Dr. Nabil ...
    Breaking Biology Technology:Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 2Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 3QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2
    ... said this week that she would like Wisconsin to double ... the Act 255 program. , ,In an interview, Burke said ... but she would like to double the tax credits from ... Act 255, which had bipartisan support, the state made available ...
    ... Wis. Small Tree Communications said it ... Chippewa Valley Angel Investing Network , which invested $445,000 in ... drivers and other products for Apple's Mac OS X. It ... million in funding has been allocated for the company to ...
    ... Wis. Fiserv, Inc. , the Brookfield-based provider ... Wisconsin companies to make the annual Fortune 500 ... , ,Fiserv, which reported $4.1 billion in annual revenue ... 488 after ranking 510th last year. The annual ranking will ...
    Cached Biology Technology:Burke would like to double Act 255 angel tax credits 2
    (Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
    (Date:11/10/2014)... on U.S. store shelves in early 2010, and people ... small packets can be tossed into a washing machine ... powder. The convenience, though, has come with risks for ... Nationwide Children,s Hospital found that from 2012 through 2013, ... younger than 6 years of age swallowing, inhaling, or ...
    (Date:11/6/2014)... TALLAHASSEE, Fla. -- A groundbreaking paper from a team ... better understanding of how plants could adapt to and ... The research, published in the latest issue of the ... how chromatin (the complex of DNA and proteins) is ... material, so that some genes are turned on and ...
    Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2Maize analysis yields whole new world of genetic science 2
    ... Nearly 50% of couples who were interviewed at least 3 ... their surplus, stored embryos for stem cell research, according to ... April 26, 2007, advanced online publication of Cell Stem Cell, ... International Society for Stem Cell Research. , The key ...
    ... MIT Media Lab have invented a way to reversibly ... the prospect of controlling the haywire neuron activity that ... , Such diseases often must be treated by removing ... lead to the development of optical brain prosthetics to ...
    ... Dick at Ontario Cancer Institute (OCI) have developed a method ... stem cells. The converted cells, when transplanted into special mice ... entire disease process from the very moment it begins. The ... Dick, Senior Scientist at OCI, the research arm of Princess ...
    Cached Biology News:Many couples choose to donate surplus embryos for stem cell research 2MIT: Pulsing light silences overactive neurons 2Cancer scientists create 'human' leukemia process to map how disease begins, progresses 2
    MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
    Goat polyclonal to DRAK2...
    MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
    ... CDX2, a member of the caudal-related ... that regulates both proliferation and differentiation in ... role in triggering cells towards the phenotype ... in the maintenance of the phenotype. Clone ...
    Biology Products: